New amendments to patent rules in India will jeopardize the country’s ability to produce generics, dealing a strong blow to access to medicines in both India and other countries of the Global South

A recent deal struck between Johnson & Johnson and the Global Drug Facility promises improved access to bedaquiline in a number of low income countries, but fails to address structural problems

The UK-India FTA could have a drastic impact on the cost of drugs as well as the timely entry of generic medicines in India and other developing countries.

Pharmaceutical companies are trying to undermine a decision of the Brazilian Supreme Court from 2021 which puts health ahead of private profit

Moderna’s filing for patents in South Africa puts a question mark on its intentions of honoring the pledge that it will not enforce patents during the pandemic. Activists fear that this may jeopardize the WHO’s technology sharing hub

The Bolivian government reached an agreement with Biolyse, a Canadian drug manufacturer, to produce additional doses of COVID-19 vaccines if a compulsory license is issued. However, their efforts have been blocked by the interest of patent-holders profiteering on the pandemic.

Newsclick’s Prabir Purkayastha talks about issues around intellectual property rights in the time of the COVID-19 pandemic.